Metoprolol Tartrate Tablets USP 100 mg — Class II drug recall D-0812-2021
Terminated recall by Aurobindo Pharma USA Inc., reported 2021-09-29, distributed nationwide. Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.
| Recall number | D-0812-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aurobindo Pharma USA Inc., East Windsor, NJ, United States |
| Recall initiated | 2021-09-09 |
| Classified | 2021-09-20 |
| Reported by FDA | 2021-09-29 |
| Terminated | 2023-10-31 |
| Distributed | Nationwide (US) |
| Quantity | 2,820 bottles |
| NDC | 65862-0062, 65862-0062-01, 65862-0062-99, 65862-0063, 65862-0063-01, 65862-0063-60, 65862-0063-99, 65862-0064, 65862-0064-01, 65862-0064-60, 65862-0064-99 |
| Lot numbers | MJ1019025-A |
| Expiration dates | 2022-04 |
Product
Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520, NDC 65862-064-99
Reason for recall
Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0812-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.